Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease

被引：0
|
作者：
Meri Tarockoff
Teresita Gonzalez
Stanislav Ivanov
Jose Sandoval-Sus
机构：
[1] Memorial Healthcare System,Department of Hematology and Oncology
[2] Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute,undefined
来源：
Current Oncology Reports | 2022年 / 24卷
关键词：
Mantle cell lymphoma; Relapsed/refractory mantle cell lymphoma; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1313 / 1326
页数：13
相关论文
共 50 条
  • [31] Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
    Maddocks, Kami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S187 - S188
  • [32] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [33] Follicular lymphoma: are we ready for a risk-adapted approach?
    Kahl, Brad S.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 358 - 364
  • [34] Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
    Wang, Jacqueline F.
    Wang, Yucai
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 651 - 659
  • [35] Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma
    Tawfiq, Reema K.
    Larson, Melissa C.
    Gile, Jennifer Jane
    Bock, Allison M.
    Poonsombudlert, Kittika
    Maliske, Seth M.
    Maurer, Matthew J.
    Cerhan, James R.
    Kabat, Brian
    Smith, Katherine
    Godby, Richard Curtis
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Wang, Yucai
    BLOOD, 2022, 140 : 6489 - 6491
  • [36] Management of Relapsed Mantle Cell Lymphoma: Still a Treatment Challenge
    Ruan, Jia
    Coleman, Morton
    Leonard, John P.
    ONCOLOGY-NEW YORK, 2009, 23 (08): : 683 - 690
  • [37] Progress in risk-adapted acute GVHD therapy
    Pidala, Joseph
    BLOOD, 2023, 141 (05) : 443 - 444
  • [38] Chronic lymphocytic leukaemia: risk-adapted therapy
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2000, 11 : 197 - 198
  • [39] Risk-adapted therapy of acute myeloid leukemia
    Hiddemann, W.
    Spiekermann, K.
    Braess, J.
    Feuring-Buske, M.
    Buske, C.
    Buechner, T.
    INTERNIST, 2006, 47 : S33 - S38
  • [40] Management of Relapsed Mantle Cell Lymphoma
    Cohen, Jonathon B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S98 - S100
12345